Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients

Journal of Clinical Immunology

Volumn 34, Issue 2, 2014, Pages 181-193

  Sarkadi, Adrien Katalin ^a   Taskó, Szilvia ^a   Csorba, Gabriella ^a   Tóth, Beáta ^a   Erdős, Melinda ^a   Maródi, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

APECED; chronic mucocutaneous candidiasis; IL 17; IL 22

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; BORATE SODIUM; CALCIUM; ENDOCRINE ORGAN ANTIBODY; FLUCONAZOLE; GENOMIC DNA; GLYCEROL; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; LIVER ENZYME; NYSTATIN; OMEGA INTERFERON; PARATHYROID HORMONE; SILYMARIN; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN B COMPLEX; VITAMIN D;

ADRENAL INSUFFICIENCY; ADULT; ALOPECIA; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BACTERIAL INFECTION; BLOOD CELL; CANDIDA; CANDIDA ALBICANS; CHICKENPOX; CHILD; CLINICAL ARTICLE; CLINICAL CHEMISTRY; CYTOKINE RELEASE; DEHYDRATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA SEQUENCE; ENAMEL HYPOPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; GENETIC ANALYSIS; GRANULOCYTOSIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGAMMAGLOBULINEMIA; HYPERPHOSPHATEMIA; HYPERTRANSAMINASEMIA; HYPOPARATHYROIDISM; IMMUNOLOGY; IMMUNOTHERAPY; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; LABORATORY TEST; LIVER PROTECTION; MALE; MONONUCLEAR CELL; MUCOCUTANEOUS CANDIDIASIS; MUSCLE CRAMP; NAIL DYSTROPHY; NONSENSE MUTATION; PARATHYROID HORMONE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; THRUSH; UPPER RESPIRATORY TRACT INFECTION; VASCULITIS; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AUTOANTIBODIES; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DNA MUTATIONAL ANALYSIS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERFERON TYPE I; INTERLEUKIN-17; INTERLEUKINS; MALE; MUTATION; PEDIGREE; POLYENDOCRINOPATHIES, AUTOIMMUNE; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84898838687     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-9987-5     Document Type: Article

References (39)

1. Ahlgren KM, Moretti S, Lundgren BA, Karlsson I, Ahlin E, Norling A, et al. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model. Eur J Immunol. 2011;41:235-45.
2. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829-36.
3. Al-Herbish AS, Bailey JD, Kooh SW. Growth hormone deficiency in autoimmune polyglandular disease type 1. Saudi Med J. 2000;21(8):765-8.
4. Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis- ectoderma dystrophy syndrome. Br J Dermatol. 2006;154(6):1088-93.
5. Cypowyj S, Picard C, Maródi L, Casanova JL, Puel A. Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol. 2012;42(9):2246-54.
6. De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010;3(4):361-73.
7. den Dunnen JT, Antonarakis E. Nomenclature for the description of human sequence variations. Hum Genet. 2001;109:121-4.
8. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol. 2008;128(11):2640-5.
9. Gupta AN, Kaniyoor Nagri S. Schmidt's syndrome - case report. Australas Med J. 2012;5(6):292-5.
10. Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265(5):514-29.
11. Kisand K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207(2):299-308.
12. Kisand K, Lilic D, Casanova JL, Peterson P, Meager A, Willcox N. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol. 2011;41:1517-27.
13. Kreuz W, Erdös M, Rossi P, Bernatowska E, Espanol T, Maródi L. A multi-centre study of efficacy and safety of intratect, a novel intravenous immunoglobulin preparation. Clin Exp Immunol. 2010;161(3):512-7.
14. Maródi L. Local and systemic host defense mechanisms against Candida: immunopathology of candidal infections. Pediatr Infect Dis J. 1997;16(8):795-801.
15. Maródi L, Cypowyj S, Tóth B, Chernyshova L, Puel A, Casanova JL. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J Allergy Clin Immunol. 2012;130(5):1019-27.
16. McManus BA, McGovern E, Moran GP, Healy CM, Nunn J, Fleming P, et al. Microbiological screening of Irish patients with autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candidiasis without culture evidence. J Clin Microbiol. 2011;49(5):1879-89.
17. Meager A, Visvalingam K, Peterson P, Möll K, Murumagi A, Krohn K, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3(7):e289.
18. Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2008;93(11):4389-97.
19. Meloni A, Willcox N, Meager A, Atzeni M, Wolff SA, Husebye ES, et al. Autoimmune polyendocrine syndroma type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab. 2012;97(4):1114-24.
20. Myhre AG, Halonen M, Eskelin P, Ekwall O, Hedstrand H, Rorsman F, et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol. 2001;54:211-7.
21. Negi VS, Elluru S, Sibéril S, Graff-Dubois S, Mouthon L, Kazatchkine MD, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007;27(3):233-45.
22. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore). 1981;60(5):355-62.
23. H 17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy. J Allergy Clin Immunol. 2010;126(5):1006-15.
24. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(4 Suppl):S525-53.
25. Perniola R, Falorni A, Clemente MG, Forini F, Accoqli E, Lobreqlio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dytrophy (APECED). Eur J Endocrinol. 2000;143(4):497-503.
26. Peterson P, Pitkanen J, Sillanpaa N, Krohn K. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: a model disease to study molecular aspects of endocrine autoimmunity. Clin Exp Immunol. 2004;135:348-57.
27. Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12(6):616-22.
28. Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291-7.
29. Puel A, Picard C, Cypowyj S, Lilic D, Abel L, Casanova JL. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol. 2010;22(4):467-74.
30. Rautemaa R, Hietanen J, Nissalo S, Pirinen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma - a complication or a component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol. 2007;43:607-13.
31. Rosa DD, Pasqualotto AC, Denning DW. Chronic mucocutaneous candidiasis and eosophageal cancer. Med Mycol. 2008;46(1):85-91.
32. Sami N, Bhol KC, Ahmed AR. Influence of IVIg therapy on autoantibody titer to desmoglein 1 in patients with pemphigus foliaceus. Clin Immunol. 2002;105(2):192-8.
33. Sibéril S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, et al. Intravenous immunoglobulins in autoimmune and inflammatory disease. Ann N Y Acad Sci. 2007;1110:497-506.
34. Thorpe ES, Handley HE. Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years. Arch Pediatr Adolesc Med. 1929;38(2):328-38.
35. Tóth B, Méhes L, Taskó S, Szalai Z, Tulassay Z, Cypowyj S, et al. Herpes in STAT1 gain-of-function mutation. Lancet. 2012;379(9835):2500.
36. Tóth B, Wolff AS, Halász Z, Tar A, Szüts P, Illyés I, et al. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy. Clin Endocrinol (Oxf). 2010;72(5):641-7.
37. Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R. Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans. Int J Cancer. 2009;124:754-6.
38. Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M. Autoimmune polyendocrine syndrome type 1: case report and review of literature. Arg Bras Endocrinol Metabol. 2012;56(1):54-66.
39. Zelante T, Iannitti R, De Luca A, Romani L. IL-22 in antifungal immunity. Eur J Immunol. 2011;41(2):270-5.